AAAAAA
Results: 51-75/792
Authors:
HARADA N
HONDA S
Citation: N. Harada et S. Honda, MOLECULAR ANALYSIS OF ABERRANT EXPRESSION OF AROMATASE IN BREAST-CANCER TISSUES, Breast cancer research and treatment, 49, 1998, pp. 15-21
Authors:
BRODIE A
LU Q
YUE W
WANG JP
LIU Y
Citation: A. Brodie et al., INTRATUMORAL AROMATASE MODEL - THE EFFECTS OF LETROZOLE (CGS-20267), Breast cancer research and treatment, 49, 1998, pp. 23-26
Authors:
MILLER WR
MULLEN P
TELFORD J
DIXON JM
Citation: Wr. Miller et al., CLINICAL IMPORTANCE OF INTRATUMORAL AROMATASE, Breast cancer research and treatment, 49, 1998, pp. 27-32
Authors:
REED,SANTEN,BHATTNAGAR,MILLER,DOWSETT,HARADA,BRODIE
Citation: Reed,santen,bhattnagar,miller,dowsett,harada,brodie, INTRATUMORAL VERSUS PERIPHERAL AROMATASE INHIBITION - DISCUSSION OF SESSION 1, Breast cancer research and treatment, 49, 1998, pp. 33-37
Authors:
DOWSETT M
Citation: M. Dowsett, THEORETICAL CONSIDERATIONS FOR THE IDEAL AROMATASE INHIBITOR, Breast cancer research and treatment, 49, 1998, pp. 39-44
Authors:
LONNING PE
Citation: Pe. Lonning, PHARMACOLOGICAL PROFILES OF EXEMESTANE AND FORMESTANE, STEROIDAL AROMATASE INHIBITORS USED FOR TREATMENT OF POSTMENOPAUSAL BREAST-CANCER, Breast cancer research and treatment, 49, 1998, pp. 45-52
Authors:
LONNING PE
GEISLER J
DOWSETT M
Citation: Pe. Lonning et al., PHARMACOLOGICAL AND CLINICAL PROFILE OF ANASTROZOLE, Breast cancer research and treatment, 49, 1998, pp. 53-57
Authors:
GOSS PE
Citation: Pe. Goss, PRECLINICAL AND CLINICAL REVIEW OF VOROZOLE, A NEW 3RD-GENERATION AROMATASE INHIBITOR, Breast cancer research and treatment, 49, 1998, pp. 59-65
Authors:
SMITH IE
NORTON A
Citation: Ie. Smith et A. Norton, FADROZOLE AND LETROZOLE IN ADVANCED BREAST-CANCER - CLINICAL AND BIOCHEMICAL EFFECTS, Breast cancer research and treatment, 49, 1998, pp. 67-71
Authors:
BHATNAGAR A
DOWSETT M
SANTEN D
SMITH I
BOEHM R
LONNING P
TEDESCHI M
LASSUS M
MILLER B
TOMINAGA T
Citation: A. Bhatnagar et al., PHARMACOLOGICAL PROFILE OF AN IDEAL AROMATASE INHIBITOR IN THE TREATMENT OF BREAST-CANCER - DISCUSSION OF SESSION 2, Breast cancer research and treatment, 49, 1998, pp. 73-77
Authors:
SASANO H
MURAKAMI H
Citation: H. Sasano et H. Murakami, IMMUNOLOCALIZATION OF AROMATASE IN HUMAN BREAST DISORDERS USING DIFFERENT ANTIBODIES, Breast cancer research and treatment, 49, 1998, pp. 79-84
Authors:
BRODIE A
LONG B
LU Q
Citation: A. Brodie et al., AROMATASE EXPRESSION IN THE HUMAN BREAST, Breast cancer research and treatment, 49, 1998, pp. 85-91
DEMONSTRATION OF AROMATASE-ACTIVITY AND ITS REGULATION IN BREAST-TUMOR AND BENIGN BREAST FIBROBLASTS
Authors:
SANTEN RJ
MARTEL J
HOAGLAND M
NAFTOLIN F
ROA L
HARADA N
HAFER L
ZAINO R
PAULEY R
SANTNER S
Citation: Rj. Santen et al., DEMONSTRATION OF AROMATASE-ACTIVITY AND ITS REGULATION IN BREAST-TUMOR AND BENIGN BREAST FIBROBLASTS, Breast cancer research and treatment, 49, 1998, pp. 93-99
Authors:
SHENTON KC
DOWSETT M
LU Q
BRODIE A
SASANO H
SACKS NPM
ROWLANDS MG
Citation: Kc. Shenton et al., COMPARISON OF BIOCHEMICAL AROMATASE-ACTIVITY WITH AROMATASE IMMUNOHISTOCHEMISTRY IN HUMAN BREAST CARCINOMAS, Breast cancer research and treatment, 49, 1998, pp. 101-107
Authors:
SASANO,DOWSETT,MILLER,SANTEN,BRODIE,BHATNAGAR,GOSS,SHENTON
Citation: Sasano,dowsett,miller,santen,brodie,bhatnagar,goss,shenton, IMMUNOHISTOCHEMICAL APPROACHES TO ASSESSING INTRATUMORAL AROMATASE - DISCUSSION OF SESSION 3, Breast cancer research and treatment, 49, 1998, pp. 109-119
Authors:
HAN EKH
ARBER N
YAMAMOTO H
LIM JTE
DELOHERY T
PAMUKCU R
PIAZZA GA
XING WQ
WEINSTEIN IB
Citation: Ekh. Han et al., EFFECTS OF SULINDAC AND ITS METABOLITES ON GROWTH AND APOPTOSIS IN HUMAN MAMMARY EPITHELIAL AND BREAST-CARCINOMA CELL-LINES, Breast cancer research and treatment, 48(3), 1998, pp. 195-203
Authors:
ZISSIS C
APOSTOLIKAS N
KONSTANTINIDOU A
GRINIATSOS J
VASSILOPOULOS PP
Citation: C. Zissis et al., THE EXTENT OF SURGERY AND PROGNOSIS OF PATIENTS WITH PHYLLODES TUMOR OF THE BREAST, Breast cancer research and treatment, 48(3), 1998, pp. 205-210
Authors:
MALATESTA M
MANNELLO F
SEBASTIANI M
CARDINALI A
MARCHEGIANI F
RENO F
GAZZANELLI G
Citation: M. Malatesta et al., ULTRASTRUCTURAL CHARACTERIZATION AND BIOCHEMICAL PROFILE OF HUMAN GROSS CYSTIC BREAST DISEASE, Breast cancer research and treatment, 48(3), 1998, pp. 211-219
Authors:
CLINE JM
SODERQVIST G
VONSCHOULTZ E
SKOOG L
VONSCHOULTZ B
Citation: Jm. Cline et al., EFFECTS OF CONJUGATED ESTROGENS, MEDROXYPROGESTERONE ACETATE, AND TAMOXIFEN ON THE MAMMARY-GLANDS OF MACAQUES, Breast cancer research and treatment, 48(3), 1998, pp. 221-229
Authors:
RICHER JK
LANGE CA
WIERMAN AM
BROOKS KM
TUNG L
TAKIMOTO GS
HORWITZ KB
Citation: Jk. Richer et al., PROGESTERONE-RECEPTOR VARIANTS FOUND IN BREAST CELLS REPRESS TRANSCRIPTION BY WILD-TYPE RECEPTORS, Breast cancer research and treatment, 48(3), 1998, pp. 231-241
Authors:
LU B
LIANG XS
SCOTT GK
CHANG CH
BALDWIN MA
THOMAS T
BENZ CC
Citation: B. Lu et al., POLYAMINE INHIBITION OF ESTROGEN-RECEPTOR (ER) DNA-BINDING AND LIGAND-BINDING FUNCTIONS, Breast cancer research and treatment, 48(3), 1998, pp. 243-257
Authors:
SORLIE T
ANDERSEN TI
BUKHOLM I
BORRESENDALE AL
Citation: T. Sorlie et al., MUTATION SCREENING OF BRCA1 USING PTT AND LOH ANALYSIS AT 17Q21 IN BREAST CARCINOMAS FROM FAMILIAL AND NONFAMILIAL CASES, Breast cancer research and treatment, 48(3), 1998, pp. 259-264
Authors:
RAO GN
NEY E
HERBERT RA
Citation: Gn. Rao et al., EFFECT OF RETINOID ANALOGS ON MAMMARY-CANCER IN TRANSGENIC MICE WITH C-NEU BREAST-CANCER ONCOGENE, Breast cancer research and treatment, 48(3), 1998, pp. 265-271
Authors:
LI PX
BUI T
GRAY D
KLAMUT HJ
Citation: Px. Li et al., THERAPEUTIC POTENTIAL OF RECOMBINANT P53 OVEREXPRESSION IN BREAST-CANCER CELLS EXPRESSING ENDOGENOUS WILD-TYPE P53, Breast cancer research and treatment, 48(3), 1998, pp. 273-286
Authors:
HOHENBERGER P
FELGNER C
HAENSCH W
SCHLAG PM
Citation: P. Hohenberger et al., TUMOR OXYGENATION CORRELATES WITH MOLECULAR GROWTH DETERMINANTS IN BREAST-CANCER, Breast cancer research and treatment, 48(2), 1998, pp. 97-106